Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elizabeth J Read

Showing results (31-40 of 39) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 39 results.
European Heart Journal|May 27, 2008
Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarctionRanil de Silva, Amish N Raval, Mohiuddin Hadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomasCrystal L Mackall, Eunice H Rhee, Elizabeth J Read, et al.
Blood|April 9, 2005
Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantationScott R Solomon, Stephan Mielke, Bipin N Savani, et al.
Journal of the American College of Cardiology|November 1, 2005
Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery diseaseJonathan M Hill, Mushabbar A Syed, Andrew E Arai, et al.
British Journal of Haematology|September 9, 2004
Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantationMichael R Bishop, Seth M Steinberg, Ronald E Gress, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2013
Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSFAndreas Lundqvist, Aleah L Smith, Yoshiyuki Takahashi, et al.
Human Gene Therapy|September 10, 2005
Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individualsRichard A Morgan, Robert Walker, Charles S Carter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcomeDavid P Carbone, I Frank Ciernik, Michael J Kelley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantationDaniel H Fowler, Jeanne Odom, Seth M Steinberg, et al.
Pageof 4

Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
European Heart Journal|May 27, 2008
Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarctionRanil de Silva, Amish N Raval, Mohiuddin Hadi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
A pilot study of consolidative immunotherapy in patients with high-risk pediatric sarcomasCrystal L Mackall, Eunice H Rhee, Elizabeth J Read, et al.
Blood|April 9, 2005
Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantationScott R Solomon, Stephan Mielke, Bipin N Savani, et al.
Journal of the American College of Cardiology|November 1, 2005
Outcomes and risks of granulocyte colony-stimulating factor in patients with coronary artery diseaseJonathan M Hill, Mushabbar A Syed, Andrew E Arai, et al.
British Journal of Haematology|September 9, 2004
Targeted pretransplant host lymphocyte depletion prior to T-cell depleted reduced-intensity allogeneic stem cell transplantationMichael R Bishop, Seth M Steinberg, Ronald E Gress, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2013
Differences in the phenotype, cytokine gene expression profiles, and in vivo alloreactivity of T cells mobilized with plerixafor compared with G-CSFAndreas Lundqvist, Aleah L Smith, Yoshiyuki Takahashi, et al.
Human Gene Therapy|September 10, 2005
Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individualsRichard A Morgan, Robert Walker, Charles S Carter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcomeDavid P Carbone, I Frank Ciernik, Michael J Kelley, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 7, 2006
Phase I clinical trial of costimulated, IL-4 polarized donor CD4+ T cells as augmentation of allogeneic hematopoietic cell transplantationDaniel H Fowler, Jeanne Odom, Seth M Steinberg, et al.
Pageof 4